Dr. Karla Saint Andre, M.D.
What this data tells you about Dr. Saint Andre
Dr. Karla Saint Andre is an endocrinology in Pearland, TX, with 11 years in practice. Based on federal Medicare data, Dr. Saint Andre performed 1,949 Medicare services across 312 unique beneficiaries.
Between the years covered by Open Payments, Dr. Saint Andre received a total of $5,429 from 31 pharmaceutical and/or device companies across 203 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Saint Andre is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 1,620 | $18 | $60 |
| Office visit, established patient (30-39 min) | 79 | $82 | $314 |
| Office visit, established patient, complex (40-54 min) | 70 | $120 | $421 |
| Drug injection, under skin or into muscle | 46 | $8 | $97 |
| Hemoglobin A1c test (diabetes monitoring) | 37 | $10 | $42 |
| Initial hospital admission, moderate complexity | 37 | $103 | $401 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 25 | $23 | $169 |
| Blood glucose (sugar) test performed by hand-held instrument | 12 | $3 | $10 |
| New patient office visit, complex (60-74 min) | 12 | $99 | $600 |
| Office visit, established patient (20-29 min) | 11 | $52 | $212 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (95%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Saint Andre is a mixed practice specialist, with above-average Medicare volume (top 23% in TX), and low-engagement industry engagement.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Saint Andre experienced with denosumab injection (prolia/xgeva)?
Does Dr. Saint Andre receive payments from pharmaceutical companies?
How do Dr. Saint Andre's costs compare to other endocrinologys in Pearland?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology